Clinical trial
Lantus in the Treatment of Type 1 Diabetes Children
NCT00206401 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00206401 |
|---|---|
| Title | Lantus in the Treatment of Type 1 Diabetes Children |
| Official title | Conventional Insulin Therapy Vs Intensive Insulin Management In Children With Type 1 Diabetes Mellitus |
| Lead sponsor | Baylor College of Medicine, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes |
| Intervention type | Drug |
| Interventions | Lantus and short acting analogs Vs NPH and short acting analogs |
| Enrollment | 60 |
| Start date | Nov 1, 2004 |
| Completion | Oct 1, 2006 |
| First posted | Sep 21, 2005 |
| Last update posted | Jul 14, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: